Translational Research in Vitiligo: Launching a new era of targeted treatment

John Harris, M.D., Assistant Professor in the Dermatology Division and Director of the Vitiligo Clinical Care and Research Center at UMMS explores emerging therapies in vitiligo.

Presenter: John Harris, M.D., Assistant Professor in the Dermatology Division and Director of the Vitiligo Clinical Care and Research Center at UMMS

Investigating Value in Everyday Dermatology

Hair, Hair, Everywhair: The Translational Journey to Elucidate the Role of JAK Inhibition in Alopecia Areata and Androgenic Alopecia

Approaches to Treating Advanced Melanoma

Time Heals All Wounds? Not Really: A Bench to Bedside Review on Cutaneous Wound Management

Robert Kirsner M.D., PhD, Professor and Harvey Blank Chair in Dermatology in the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine challenges us with practical, translational pearls on wound care in this installment of the GW/JDD Translational Science Lecture Series. What is the best way to manage wound pain? Are scarless graft donor sites related to the easter bunny? What’s mo(i)st important for wound bandaging? Let’s be clear – ALL DERMATOLOGISTS SHOULD WATCH THIS.

Special thanks to Sun Pharma, for support of and exhibition at this event.

“I see Sezary cells:” Exploring the Molecular Basis of CTCL to Identify Better Treatments

Madeleine Duvic, M.D., Professor of Internal Medicine and Deputy Chairman of the Department of Dermatology at The University of Texas, MD Anderson Cancer Center in Houston, Texas, explores the molecular underpinnings of CTCL to highlight targets for established and emerging therapies.

Inante Immune Mechanisims – Translation to Novel Therapeutics For Skin Disease

Dr. Lloyd Miller, Associate Professor of Dermatology and Orthopedic Surgery at the Johns Hopkins School of Medicine, takes us on a translational tour of the innate immune response, highlighting specific aberrations in cutaneous pathology and drugable targets.

Special thanks to Novatis, Lilly, Allergan, Celgene, and Sanofi Regeneron, for support of and exhibition at this event.

Advances in Melanoma Risk Assessment and Metastatic Disease Monitoring

Dr. David Polsky, Professor of Dermatology and Pathology, Alfred W. Kopf, MD Professor of Dermatologic Oncology in the Department of Dermatology at NYU Langone Medical Center delivers a stelar presentation on both developing tools to better stratify risk factors for melanoma, and identifying novel biomarkers to allow for melanoma treatment efficacy monitoring and progress.

Special thanks to Genentech for support of and exhibition at this event.

Targeting cAMP Signaling for the Treatment of Inflammatory Diseases of the Skin

Dr. Jon Zippin, Assistant Attending Dermatologist and Assistant Professor of Dermatology at Weill Medical College of Cornell, elucidates the complexity of cAMP biology and the translational impact of PDE4 inhibition as it relates to chronic inflammatory skin diseases. Tune in to learn why targeting this pathway is clinically meaningful but also where more work is needed to improve outcomes.

Special thanks to Celgene and Pfizer for support of and exhibition at this event.

Translational Research in Acne: Identifying Therapeutic Targets

Dr. Diane Thiboutot, endowed Professor of Dermatology and Associate Dean of Clinical and Translational Research Education at the Pennsylvania State University College of Medicine in Hershey, PA, underscores the extraordinary biological complexity of one of the most common skin diseases, Acne Vulgaris.

Special thanks to Valeant, Bayer, and Allergan for support and/or exhibition at the live activity.

Update on Pediatric Inflammatory Skin Disorders: How Pathogenesis Informs Treatment

Dr. Amy Paller, Walter J. Hamlin Professor and Chair of Dermatology & Professor of Pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois, delivers a presentation discussing the cause and treatment of pediatric Atopic Dematitis, including co-morbidities, epidermal barrier impairment, and compliance issues.

Special thanks to Encore Dermatology for support and/or exhibition at the live activity.

Psoriasis: Biological Basis for Comorbidities

Dr. Abrar Qureshi, Professor and Chair of Department of Dermatology at The Warren Alpert Medical School of Brown University, reviews his research to uncover the biological basis for many of the co-morbidities associated with, and risk factors for, psoriasis. Through this clear and clinically oriented presentation, the common pathophysiological threads are elucidated with a focus on identifying preventive strategies and therapeutic targets for current and future treatments.

Special thanks to Celgene, Leo Pharma, Eli Lilly, and AbbVie for support and/or exhibition at the live activity.